Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells

European Journal of Immunology

Volumn 41, Issue 7, 2011, Pages 1958-1968

  Matthews, Nick C ^a   Goodier, Martin R ^a   Robey, Rebecca C ^a   Bower, Mark ^a   Gotch, Frances M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Immune evasion; Kaposi's sarcoma associated herpesvirus; NK cells

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; HLA E ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D;

ARTICLE; CELL KILLING; CONTROLLED STUDY; CYTOTOXICITY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; KAPOSI SARCOMA; LATENT VIRUS INFECTION; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SPINDLE CELL; VIRUS LOAD;

CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FIBROBLASTS; FLOW CYTOMETRY; GENE EXPRESSION; HERPESVIRUS 8, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PHENOTYPE; POLYMERASE CHAIN REACTION; SARCOMA, KAPOSI; VIRUS LATENCY;

EID: 79959742709     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040661     Document Type: Article

References (45)

1. Cesarman, E., Moore, P. S., Rao, P. H., Inghirami, G., Knowles, D. M. and Chang, Y., In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 1995. 86: 2708-2714.
2. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M. et al., Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995. 86: 1276-1280.
3. Friedman-Kien, A. E. and Saltzman, B. R., Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J. Am. Acad. Dermatol. 1990. 22: 1237-1250.
4. Stevenson, P. G., Immune evasion by gamma-herpesviruses. Curr. Opin. Immunol. 2004. 16: 456-462.
5. Simpson, G. R., Schulz, T. F., Whitby, D., Cook, P. M., Boshoff, C., Rainbow, L., Howard, M. et al., Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996. 348: 1133-1138.
6. Wilkinson, J., Cope, A., Gill, J., Bourboulia, D., Hayes, P., Imami, N., Kubo, T. et al., Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-Infected patients receiving highly active antiretroviral therapy. J. Virol. 2002. 76: 2634-2640.
7. Micheletti, F., Monini, P., Fortini, C., Rimessi, P., Bazzaro, M., Andreoni, M., Giuliani, M. et al., Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8. Immunology 2002. 106: 395-403.
8. + T cell epitopes within lytic antigens of human herpes virus 8. J. Immunol. 2006. 176: 923-930.
9. Wang, H. W., Trotter, M. W., Lagos, D., Bourboulia, D., Henderson, S., Makinen, T., Elliman, S. et al., Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 2004. 36: 687-693.
10. Penn, I., Kaposi's sarcoma in transplant recipients. Transplantation 1997. 64: 669-673.
11. Lebbe, C., Blum, L., Pellet, C., Blanchard, G., Verola, O., Morel, P., Danne, O. and Calvo, F., Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS 1998. 12: F45-F49.
12. Wei, B. L., Arora, V. K., Foster, J. L., Sodora, D. L. and Garcia, J. V., In vivo analysis of Nef function. Curr. HIV Res. 2003. 1: 41-50.
13. Lopez-Botet, M., Llano, M. and Ortega, M., Human cytomegalovirus and natural killer-mediated surveillance of HLA class I expression: a paradigm of host-pathogen adaptation. Immunol. Rev. 2001. 181: 193-202.
14. Llano, M., Guma, M., Ortega, M., Angulo, A. and Lopez-Botet, M., Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK-cell subsets. Eur. J. Immunol. 2003. 33: 2744-2754.
15. Dantuma, N. P., Sharipo, A. and Masucci, M. G., Avoiding proteasomal processing: the case of EBNA1. Curr. Top. Microbiol. Immunol. 2002. 269: 23-36.
16. Ishido, S., Wang, C., Lee, B. S., Cohen, G. B. and Jung, J. U., Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 2000. 74: 5300-5309.
17. Coscoy, L. and Ganem, D., Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 2000. 97: 8051-8056.
18. Yokoyama, W. M., Kim, S. and French, A. R., The dynamic life of natural killer cells. Annu. Rev. Immunol. 2004. 22: 405-429.
19. Thomas, M., Boname, J. M., Field, S., Nejentsev, S., Salio, M., Cerundolo, V., Wills, M. and Lehner, P. J., Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK-cell cytotoxicity. Proc. Natl. Acad. Sci. USA 2008. 105: 1656-1661.
20. Li, Q., Means, R., Lang, S. and Jung, J. U., Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J. Virol. 2007. 81: 2117-2127.
21. Krishnan, H. H., Naranatt, P. P., Smith, M. S., Zeng, L., Bloomer, C. and Chandran, B., Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 2004. 78: 3601-3620.
22. Adang, L. A., Tomescu, C., Law, W. K. and Kedes, D. H., Intracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components. J. Virol. 2007. 81: 5079-5090.
23. Biron, C. A., Byron, K. S. and Sullivan, J. L., Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 1989. 320: 1731-1735.
24. Sirianni, M. C., Vincenzi, L., Topino, S., Giovannetti, A., Mazzetta, F., Libi, F., Scaramuzzi, D. et al., NK-cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma. Eur. J. Immunol. 2002. 32: 2711-2720.
25. Coscoy, L. and Ganem, D., A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Invest. 2001. 107: 1599-1606.
26. Ishido, S., Choi, J. K., Lee, B. S., Wang, C., DeMaria, M., Johnson, R. P., Cohen, G. B. and Jung, J. U., Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 2000. 13: 365-374.
27. Sakurada, S., Katano, H., Sata, T., Ohkuni, H., Watanabe, T. and Mori, S., Effective human herpesvirus 8 infection of human umbilical vein endothelial cells by cell-mediated transmission. J. Virol. 2001. 75: 7717-7722.
28. Vieira, J., O'Hearn, P., Kimball, L., Chandran, B. and Corey, L., Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J. Virol. 2001. 75: 1378-1386.
29. Tomescu, C., Law, W. K. and Kedes, D. H., Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus. J. Virol. 2003. 77: 9669-9684.
30. Michon, J. M., Caligiuri, M. A., Hazanow, S. M., Levine, H., Schlossman, S. F. and Ritz, J., Induction of natural killer effectors from human thymus with recombinant IL-2. J. Immunol. 1988. 140: 3660-3667.
31. Zitvogel, L., Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 2002. 195: F9-F14.
32. Jelaska, A. and Korn, J. H., Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts. J. Cell. Physiol. 1998. 175: 19-29.
33. Sedger, L. M., Shows, D. M., Blanton, R. A., Peschon, J. J., Goodwin, R. G., Cosman, D. and Wiley, S. R., IFN-gamma mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J. Immunol. 1999. 163: 920-926.
34. Ozdemir, O., Ravindranath, Y. and Savasan, S., Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells. J. Immunother. 2005. 28: 44-52.
35. Nachmani, D., Stern-Ginossar, N., Sarid, R. and Mandelboim, O., Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 2009. 5: 376-385.
36. Chang, J., Renne, R., Dittmer, D. and Ganem, D., Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 2000. 266: 17-25.
37. Dittmer, D. P., Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res. 2003. 63: 2010-2015.
38. Lagunoff, M., Bechtel, J., Venetsanakos, E., Roy, A. M., Abbey, N., Herndier, B., McMahon, M. and Ganem, D., De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells. J. Virol. 2002. 76: 2440-2448.
39. Lagos, D., Trotter, M. W., Vart, R. J., Wang, H. W., Matthews, N. C., Hansen, A., Flore, O. et al., Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. Blood 2007. 109: 1550-1558.
40. Davis, D. A., Rinderknecht, A. S., Zoeteweij, J. P., Aoki, Y., Read-Connole, E. L., Tosato, G., Blauvert, A. et al., Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 2001. 97: 3244-3250.
41. Goodier, M. R., Mela, C. M., Steel, A., Gazzard, B., Bower, M. and Gotch, F., NKG2C+NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma. J. Virol. 2007. 81: 430-433.
42. Guma, M., Angulo, A., Vilches, C., Gomez-Lozano, N., Malats, N. and Lopez-Botet, M., Imprint of human cytomegalovirus infection on the NK-cell receptor repertoire. Blood 2004. 104: 3664-3671.
43. d'Ettorre, G., Forcina, G., Lichtner, M., Mengoni, F., D'Agostino, C., Massetti, A. P., Mastroianni, C. M. and Vullo, V., Interleukin-15 in HIV infection: immunological and virological interactions in antiretroviral-naive and -treated patients. AIDS 2002. 16: 181-188.
44. Bourboulia, D., Aldam, D., Lagos, D., Allen, E., Williams, I., Cornforth, D., Copas, A. and Boshoff, C., Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia. AIDS 2004. 18: 485-493.
45. Whitcombe, D., Theaker, J., Guy, S. P., Brown, T. and Little, S., Detection of PCR products using self-probing amplicons and fluorescence. Nat. Biotechnol. 1999. 17: 804-807.